Found 20 matching trials
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer PHASE2 The main purpose of this study is to evaluate the safety of each study vacc...
Show More Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Learn More & Join Trial
Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab PHASE2 The purpose of the study is to find out if an investigational drug called D...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma PHASE1 Single center, phase I/II randomized 2-arm study, evaluating two different ...
Show More Location
Multiple Locations
Learn More & Join Trial
Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer PHASE1 This phase I/IIa trial studies the side effects and best dose of a type of ...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer N/A Immune-based therapies (vaccines) are a new focus of clinical investigation...
Show More Status
No Longer Available
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer PHASE1 This is a pilot study to determine feasibility and safety of the combinatio...
Show More Status
Active Not Recruiting
Location
Moffitt Cancer Center
Learn More & Join Trial
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer PHASE2 This study will evaluate the feasibility, safety, and efficacy of intraderm...
Show More Location
University of Pittsburgh Cancer institute
Learn More & Join Trial
DC Vaccine for Patients With Ductal Carcinoma In Situ PHASE1 Women who are diagnosed with Her-2/neu over-expressing DCIS will receive DC...
Show More Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer PHASE2 This trial proposes to evaluate the immunologic and potential clinical effe...
Show More Location
UMPC Hillman Cancer Center
Learn More & Join Trial
Autologous Dendritic Cell Vaccine in Kidney Cancer PHASE2 The purpose of this study is to estimate the probability of immune response...
Show More Location
UPMC Department of Urology
Learn More & Join Trial